A survival model for patients with ccRCC based on four of these genes (CD44, DPP4, NCOA4, and SLC7A11) demonstrated excellent prognostic efficacy, and risk scoring was an independent factor for prognosis prediction (102). Here, CD44 is linked to nonpapillary renal cell carcinoma.